Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Induced Movement Disorder”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Post-approval studies (Phase 4)Study completedNCT05859698
What this trial is testing

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 59
Not applicableStudy completedNCT00579267
What this trial is testing

Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

Who this might be right for
Major DepressionManiaAnxiety Disorders+11 more
University of South Florida 230
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Large-scale testing (Phase 3)Study completedNCT02274558
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 234
Testing effectiveness (Phase 2)Ended earlyNCT00693472
What this trial is testing

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Who this might be right for
Akathisia, Drug-InducedAntipsychotic AgentsMovement Disorders
Merck Sharp & Dohme LLC 46
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Large-scale testing (Phase 3)WithdrawnNCT03254186
What this trial is testing

Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Emory University
Testing effectiveness (Phase 2)UnknownNCT00331669
What this trial is testing

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

Who this might be right for
DystoniaMovement Disorder
Charite University, Berlin, Germany 24
Post-approval studies (Phase 4)Study completedNCT00926965
What this trial is testing

Tardive Dyskinesia and Cognitive Function

Who this might be right for
Tardive DyskinesiaNeurocognitive Function
Taipei Veterans General Hospital, Taiwan 80
Testing effectiveness (Phase 2)Study completedNCT01267188
What this trial is testing

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 10
Not applicableStudy completedNCT02761707
What this trial is testing

Biomarkers in Neural Disorders

Who this might be right for
Parkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear Palsy+6 more
University of Pennsylvania 54
Large-scale testing (Phase 3)Study completedNCT00291213
What this trial is testing

Levetiracetam Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Yale University 50
Not applicableStudy completedNCT03354455
What this trial is testing

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 20
Not applicableStudy completedNCT01391390
What this trial is testing

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Who this might be right for
Tardive Dyskinesia
Beijing HuiLongGuan Hospital 120
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Not applicableStudy completedNCT00955604
What this trial is testing

Azilect + Antidepressant Chart Review

Who this might be right for
Serotonin Syndrome
Teva Branded Pharmaceutical Products R&D, Inc. 1,500
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Testing effectiveness (Phase 2)Study completedNCT00401089
What this trial is testing

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderTardive Dyskinesia+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Not applicableUnknownNCT02361255
What this trial is testing

Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism

Who this might be right for
Secondary ParkinsonismParkinson's Disease
Corporal Michael J. Crescenz VA Medical Center 40
Next Page